CPRT
Copart, Inc.
CPRT's fundamentals are mixed, but it looks cheap: trading at 21x earnings, below its usual 34x. Analysts expect earnings growth.
EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
CPRT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CPRT's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CPRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $32.00 | โ |
| Current | 21x | $32.00 | โ |
| Cheap | 24x | $37.74 | +18% |
| Fair | 34x | $53.05 | +66% |
| Expensive | 39x | $60.99 | +91% |
Historical ranges are pointers, not guarantees.
CPRT's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
CPRT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CPRT, but weaker profitability.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CPRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | +7% |
| Q3 2026 | $1.55 | -2.5% |
| Q2 2026 | $1.60 | +4.6% |
| Q1 2026 | $1.59 | +6% |
| Q4 2025 | $1.63 | +14% |
| Q3 2025 | $1.59 | +14% |
| Q2 2025 | $1.53 | +7.7% |
| Q1 2025 | $1.50 | +7.9% |
| Q4 2024 | $1.43 | +5.1% |
CPRT has the stronger earnings trend. Trailing diluted EPS is down 2.5% for CPRT versus EOSE down 224%.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
CPRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +2.4% |
| Q2 2026 | $1.2B | +2.1% |
| Q1 2026 | $1.1B | -3.6% |
| Q4 2025 | $1.2B | +0.7% |
| Q3 2025 | $1.1B | +5.2% |
| Q2 2025 | $1.2B | +7.5% |
| Q1 2025 | $1.2B | +14% |
| Q4 2024 | $1.1B | +12% |
CPRT's revenue grew through 2024 and has held roughly level since: $1.2B last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -4.7 points |
| Q2 2026 | 38% | +0.3 points |
| Q1 2026 | 35% | -2 points |
| Q4 2025 | 37% | +1.9 points |
| Q3 2025 | 37% | +3 points |
| Q2 2025 | 37% | -1.5 points |
| Q1 2025 | 37% | -0.6 points |
| Q4 2024 | 35% | -3.3 points |
CPRT has the edge over EOSE on profitability, with a higher operating margin.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over CPRT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
CPRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $278.7M | -21% |
| Q2 2026 | $503.3M | -20% |
| Q1 2026 | $57.9M | +1330% |
| Q4 2025 | $427.2M | +74% |
| Q3 2025 | $350.8M | +16% |
| Q2 2025 | $630.4M | +54% |
| Q1 2025 | $4M | -90% |
| Q4 2024 | $245.5M | +15% |
CPRT has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
CPRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -2.7x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
CPRT has more cash than debt.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CPRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 63.3 | Neutral |
CPRT's weekly RSI is 53 (neutral) and its Stochastic is 63 (neutral).
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CPRT PE vs Industrials Sector
| Metric | CPRT | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 24x | 14% below |
| PE % | 7 | 58 | 51 pts below |
CPRT is trading at 21x earnings, a 14% discount to the Industrials sector's median of 24x.
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
CPRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.9% above |
| 20 week MA | $29.8 | 7.3% above |
| 50 week MA | $33.3 | 3.8% below |
| 100 week MA | $42.3 | 24% below |
| 200 week MA | $45.1 | 29% below |
CPRT has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
CPRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $30.9 | +36% |
| 2021 | $30.9 | $36.5 | +18% |
| 2022 | $36.5 | $30.3 | -17% |
| 2023 | $30.3 | $49.0 | +62% |
| 2024 | $49.0 | $58.5 | +19% |
| 2025 | $58.5 | $39.3 | -33% |
| 2026 YTD | $39.3 | $32.0 | -19% |
CPRT has the edge over EOSE on returns for 2026, with the stronger performance.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to โ87% in 2022. It's down 85% so far in 2026.